Title |
Biomarkers of a five-domain translational substrate for schizophrenia and schizoaffective psychosis
|
---|---|
Published in |
Biomarker Research, February 2015
|
DOI | 10.1186/s40364-015-0028-1 |
Pubmed ID | |
Authors |
Stephanie Fryar-Williams, Jörg E Strobel |
Abstract |
The Mental Health Biomarker Project (2010-2014) selected commercial biochemistry markers related to monoamine synthesis and metabolism and measures of visual and auditory processing performance. Within a case-control discovery design with exclusion criteria designed to produce a highly characterised sample, results from 67 independently DSM IV-R-diagnosed cases of schizophrenia and schizoaffective disorder were compared with those from 67 control participants selected from a local hospital, clinic and community catchment area. Participants underwent protocol-based diagnostic-checking, functional-rating, biological sample-collection for thirty candidate markers and sensory-processing assessment. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Australia | 1 | 50% |
Unknown | 1 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Japan | 1 | <1% |
Unknown | 325 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 190 | 58% |
Student > Master | 28 | 9% |
Researcher | 18 | 6% |
Other | 14 | 4% |
Student > Doctoral Student | 8 | 2% |
Other | 21 | 6% |
Unknown | 47 | 14% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 58 | 18% |
Chemistry | 39 | 12% |
Biochemistry, Genetics and Molecular Biology | 34 | 10% |
Engineering | 25 | 8% |
Medicine and Dentistry | 24 | 7% |
Other | 94 | 29% |
Unknown | 52 | 16% |